American Vanguard Q2 EPS -$0.42; cuts FY2024 EBITDA guidance to $40-50M; EPA suspends Dacthal

AMERICAN VANGUARD CORP

2024-Q2 EPS reported -$0.36 revenue$263,352,000

Net sales $128.2M vs $132.8M Q2; Adj EBITDA $6.2M vs $10.7M; EPS $(0.42) vs $(0.04).
FY2024 guidance cut: Adj EBITDA now $40-50M (prev. $60-70M); net sales down 2% to flat (prev. +6-9%).
EPA issued emergency suspension of Dacthal; company had voluntarily paused sales in April 2024.
New credit agreement relaxes EBITDA covenant through Q3 2025; upsizes excluded charges; increases rates at high leverage.
Workforce reduced ~4%; seeking partner for SIMPAS; targeting 15% Adj EBITDA margins by 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.